Newpath Partners Launches Fund II to Create Life Sciences Co

/PRNewswire/ -- Newpath Partners, a venture firm dedicated to life science investments, today announced the launch of Fund II. With its second fund in three...

Related Keywords

Boston , Massachusetts , United States , Whitehead Institute , Massachusetts Institute Of Technology , Harvard University , Catherine Stehman Breen , Thomasj Cahill , Siddhartha Mukherjee , Daniel Getts , Jim Wells , Michael Rosbash , Keith Joung , Matt Ottmer , Ben Cravatt , Stuart Schreiber , Thomas Cahill , Michael Bruce , Luba Greenwood , Stephen Pagliuca , David Liu , Vic Meyer , Keith Gottesdiener , Jonathan Weissman , Ron Vale , Scripps Research Institute , Brandeis University , Harvard Medical School , Columbia University Medical Center , Professor At Harvard University , Janelia Research Campus , Newpath Fund , Broad Institute Of Harvard , Founder Of The Broad Institute , University Of California San Francisco , Newpath Partners , Stop Covid , Massachusetts General Hospital , Broad Institute , Executive Director , Massachusetts Institute , California San Francisco , Chroma Medicine , Nexo Therapeutics , Kisbee Therapeutics , Kojin Therapeutics , Myeloid Therapeutics , Prime Medicine , Bain Capital , Boston Celtics , Chief Executive Officer , P , Health Care Amp Hospitals , Medical Pharmaceuticals , Banking Amp Financial Services ,